Sign in
CompletedNo phase

Feasibility of a Virtual Smoking Cessation Program

Key facts

Who runs it
University Health Network, Toronto
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
54 people enrolled
Started
1 Dec 2022
Ended
11 Sept 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Virtual Smoking Cessation Program
Record updated
30 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • 18+ years of age
  • Daily or non-daily smoker
  • Self-reported smokers who have smoked cigarettes within the past 30 days
  • Must be a patient at Toronto Western Hospital or Women's College Hospital who is:; Scheduled for an elective surgical procedure that will occur at least 48 hours after recruitment OR; Visiting the fracture clinic (UHN) within and including 14 days from the initial date of injury or operation
  • Must have a working e-mail address

Who cannot take part

  • Currently on pharmacological therapy for smoking cessation
  • Drug or alcohol abuse or dependence within the past year
  • Patients who have any form of cognitive impairment,
  • Patients who have already quit smoking for more than 30 days,
  • Patients who cannot read and understand English,
  • Patients who do not have a telephone (for follow-up)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this pilot study of a clinical trial is to learn about the acceptability and feasibility of a virtual smoking cessation program in both the perioperative and fracture clinic settings. The main questions this study aims to answer are:

Read full original descriptionShow less

* The number of people that participate in the virtual smoking cessation program * The acceptability of the number, length, content, and delivery of the email messages provided by the program.

Participants will be asked to subscribe to our virtual intervention which will include:

* A smoking cessation e-learning module component to provide education on the risks of smoking in the surgical or fracture clinic setting, and * An emailing program component that will provide tailored email messages over a 30-45 day period depending on a patient's Fagerstrom test for nicotine dependence score and motivation to quit smoking.

Researchers will also compare the virtual smoking cessation program to standard care to see if there are any differences shown between both groups in the Fagerstrom test for nicotine dependence scores, number of cigarettes smoked, number of quit attempts, complication rates, and re-admission rates at the 7 day and 30 day time points.

The 2 groups in the trial

  • Intervention Arm: Virtual GroupTreatment being tested

    The intervention will involve participating in the study's virtual smoking cessation program. This program consists of 2 components: an e-learning module and a tailored email messaging program based on the participant's motivation to quit smoking and their Fagerstrom test for nicotine dependence score.

    Treatment: Virtual Smoking Cessation Program

  • Control Arm: Standard CareNo study treatment, for comparison

    This arm will receive standard care which may or may not include brief advice to quit smoking from any of the healthcare providers. Providing smoking cessation intervention is not mandatory in standard care and may not be provided.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development and Evaluation Of A Virtual Smoking Cessation Program - A Pilot Study
Record updated
30 March 2025